Gil Bornstein

2.0k total citations · 2 hit papers
33 papers, 1.6k citations indexed

About

Gil Bornstein is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Gil Bornstein has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Rheumatology and 7 papers in Molecular Biology. Recurrent topics in Gil Bornstein's work include Vasculitis and related conditions (7 papers), Ubiquitin and proteasome pathways (5 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Gil Bornstein is often cited by papers focused on Vasculitis and related conditions (7 papers), Ubiquitin and proteasome pathways (5 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Gil Bornstein collaborates with scholars based in Israel, United States and Russia. Gil Bornstein's co-authors include Avram Hershko, Michele Pagano, Dvora Ganoth, Danielle Sitry-Shevah, Joanna Bloom, Keiko Nakayama, Brett Larsen, Tun Kiat Ko, Mike Tyers and Chagai Grossman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Gil Bornstein

33 papers receiving 1.5k citations

Hit Papers

The cell-cycle regulatory protein Cks1 is required for SC... 2001 2026 2009 2017 2001 2003 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gil Bornstein Israel 15 1.1k 676 208 207 175 33 1.6k
Genine Winslow United States 8 908 0.8× 837 1.2× 55 0.3× 141 0.7× 116 0.7× 8 2.1k
Erik Springer Germany 15 468 0.4× 380 0.6× 104 0.5× 82 0.4× 137 0.8× 30 1.0k
Taizo Tasaka Japan 23 724 0.7× 936 1.4× 324 1.6× 118 0.6× 303 1.7× 91 2.0k
Miron Prokocimer Israel 22 1.2k 1.1× 860 1.3× 149 0.7× 140 0.7× 103 0.6× 60 2.3k
A Bybee United Kingdom 20 1.4k 1.3× 318 0.5× 100 0.5× 81 0.4× 141 0.8× 35 1.9k
Ghislaine Bernard France 20 511 0.5× 226 0.3× 92 0.4× 379 1.8× 54 0.3× 28 1.5k
N Arakaki Japan 15 775 0.7× 275 0.4× 154 0.7× 118 0.6× 471 2.7× 22 2.1k
Michael J. Mant Canada 26 918 0.8× 437 0.6× 218 1.0× 104 0.5× 102 0.6× 71 2.2k
S Fuggle United Kingdom 15 508 0.5× 178 0.3× 106 0.5× 127 0.6× 86 0.5× 33 1.4k
Peter Kaskel Germany 18 541 0.5× 458 0.7× 77 0.4× 127 0.6× 394 2.3× 43 1.5k

Countries citing papers authored by Gil Bornstein

Since Specialization
Citations

This map shows the geographic impact of Gil Bornstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Bornstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Bornstein more than expected).

Fields of papers citing papers by Gil Bornstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gil Bornstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Bornstein. The network helps show where Gil Bornstein may publish in the future.

Co-authorship network of co-authors of Gil Bornstein

This figure shows the co-authorship network connecting the top 25 collaborators of Gil Bornstein. A scholar is included among the top collaborators of Gil Bornstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gil Bornstein. Gil Bornstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freund, Ophir, et al.. (2023). Diagnostic delays among COVID‐19 patients with a second concurrent diagnosis. Journal of Hospital Medicine. 18(4). 321–328. 13 indexed citations
2.
Freund, Ophir, et al.. (2023). Effect of patient COVID-19 vaccine hesitancy on hospital care team perceptions. World Journal of Clinical Cases. 11(4). 821–829. 3 indexed citations
3.
Zahler, David, et al.. (2023). Rate and predictors of blood culture positivity after antibiotic administration: a prospective single-center study. Infection. 52(2). 483–490. 7 indexed citations
4.
Merdler, Ilan, Ariel Banai, Itamar Loewenstein, et al.. (2023). Serial Measurements of Neutrophil Gelatinase-Associated Lipocalin levels for Assessment of Contrast Induced Nephropathy among Chronic Kidney Disease Patients Who Underwent Elective Coronary Angiography.. PubMed. 25(5). 341–345. 1 indexed citations
5.
Freund, Ophir, Tali Eviatar, & Gil Bornstein. (2022). Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: a case series and literature review. Rheumatology International. 42(5). 905–912. 17 indexed citations
6.
Freund, Ophir, et al.. (2022). Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era. PLoS ONE. 17(5). e0268050–e0268050. 15 indexed citations
7.
Bornstein, Gil, et al.. (2020). Incidence and risk factors of pneumothorax following pre-procedural ultrasound-guided thoracentesis. Journal of Thoracic Disease. 12(3). 942–948. 8 indexed citations
8.
Gilboa, Mayan, Gil Bornstein, Ilan Ben‐Zvi, & Chagai Grossman. (2019). Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review. Rheumatology International. 40(4). 663–669. 18 indexed citations
9.
Bornstein, Gil, et al.. (2018). Hematological malignancies mimicking rheumatic syndromes: case series and review of the literature. Rheumatology International. 38(9). 1743–1749. 7 indexed citations
10.
Bornstein, Gil, Merav Lidar, Pnina Langevitz, et al.. (2018). The prevalence and clinical effect of immunogenicity of TNF-α blockers in patients with axial spondyloarthritis.. PubMed. 36(2). 228–232. 9 indexed citations
11.
Shovman, Ora, Boris Gilburd, ‬‬‬‬Abdulla Watad, et al.. (2018). The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 32(4). 610–617. 11 indexed citations
12.
Grossman, Chagai, Iris Barshack, Nira Koren‐Morag, Ilan Ben‐Zvi, & Gil Bornstein. (2017). Risk factors for severe cranial ischaemic events in patients with giant cell arteritis.. PubMed. 35 Suppl 103(1). 88–93. 8 indexed citations
13.
Shlomai, Gadi, Anat Berkovitch, Gil Bornstein, et al.. (2016). The association between normal-range admission potassium levels in Israeli patients with acute coronary syndrome and early and late outcomes. Medicine. 95(23). e3778–e3778. 14 indexed citations
14.
Grossman, Chagai, Ilan Ben‐Zvi, Iris Barshack, & Gil Bornstein. (2016). Association between specimen length and diagnostic yield of temporal artery biopsy. Scandinavian Journal of Rheumatology. 46(3). 222–225. 17 indexed citations
15.
Grossman, Chagai, Iris Barshack, Nira Koren‐Morag, Ilan Ben‐Zvi, & Gil Bornstein. (2016). Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy. Clinical Rheumatology. 35(7). 1817–1822. 26 indexed citations
16.
Bornstein, Gil & Chagai Grossman. (2015). COP9-Signalosome deneddylase activity is enhanced by simultaneous neddylation: insights into the regulation of an enzymatic protein complex. Cell Division. 10(1). 5–5. 5 indexed citations
17.
Bornstein, Gil, et al.. (2015). Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review. Clinical Rheumatology. 35(8). 2125–2130. 28 indexed citations
18.
Bornstein, Gil, Dvora Ganoth, & Avram Hershko. (2006). Regulation of neddylation and deneddylation of cullin1 in SCF Skp2 ubiquitin ligase by F-box protein and substrate. Proceedings of the National Academy of Sciences. 103(31). 11515–11520. 113 indexed citations
19.
Bornstein, Gil, Joanna Bloom, Danielle Sitry-Shevah, et al.. (2003). Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase. Journal of Biological Chemistry. 278(28). 25752–25757. 401 indexed citations breakdown →
20.
Ganoth, Dvora, Gil Bornstein, Tun Kiat Ko, et al.. (2001). The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27. Nature Cell Biology. 3(3). 321–324. 414 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026